(Q28308112)

2

0 references

Takuro Saito

3

0 references

Takayuki Anazawa

4

0 references

Akira Kenjo

5

0 references

Yoshihiro Sato

6

0 references

Takao Tsuchiya

7

0 references

Mitsukazu Gotoh

Journal of Hepato-biliary-Pancreatic Sciences

8

0 references

language of work or name

English

0 references

publication date

September 2011

0 references

published in

1 reference

describes a project that uses

PubMed

volume

18

0 references

page(s)

700-11

0 references

issue

5

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

https://scigraph.springernature.com/pub.10.1007/s00534-011-0376-7

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

A review and update on cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Diagnosis and treatment of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Nucleoside analogues and nucleobases in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

The role of glutathione-S-transferase in anti-cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7

Genetic factors influencing pyrimidine-antagonist chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0376-7